Studies in transgenic mice overexpressing the mitochondrial monoamine oxidase-A (MAO-A), an enzyme related to cardiomyopathies, showed that transgenic hearts exhibited p53 accumulation and downregulation of PGC-1α (Villeneuve et al., 2013), similar to what is observed in HD neurons. The gene discussed is TP53; the disease is Huntington disease.